Back

The optimal cut-off threshold of soluble suppressor of tumorigenicity 2 for prognostication in acute decompensated heart failure

12 May 2024 (11:00 - 11:45)
Organised by: Logo
Congress Presentation Part of: Acute heart failure - diagnostic methods 1 Biomarkers HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Brian Li

Essex Cardiothoracic Centre, Basildon (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail
Early feasibility study of a prototype device to non-invasively measure cardiac and pulmonary vascular pressures
Mr M. Mace (Helsingborg, SE)
Abstract Slides Video
Presentation thumbnail
The spot urine sodium-to-urine creatinine ratio outperforms urine sodium alone in the identification of patients with poor diuretic response in acute heart failure.
Mr G. Iwanek (Wroclaw, PL)
Abstract Slides Video
Presentation thumbnail
Bioimpedance spectroscopy evaluation of subclinical hypervolemia in heart failure patients: a comprehensive analysis
Doctor B. Braganca (Porto, PT)
Abstract Slides Video
Presentation thumbnail
Implementing an automated NT-proBNP linked heart failure referral and triage system in secondary care leads to increased heart failure specialist referral rates and reduced inpatient mortality.
Doctor M. Stanley (London, GB)
Abstract Slides Video
Presentation thumbnail
Urinary insulin-like growth factor binding protein 7 and tissue inhibitor of metalloproteinase 2 and diuretic efficiency in acute heart failure
Mr G. Nunez Marin (Valencia, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Acute heart failure - diagnostic methods 1

The Event

Event poster

Heart Failure 2024

12 May 2024 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Correlation and utility of the changes in sST2 level at clinician determined decompensation and recompensation
thumbnail
Congress Presentation
Correlation of sST2 with chosen biochemical parameters and influence on prognosis in patients hospitalized due to HFrEF.
thumbnail
Congress Presentation
Pathophysiological pathways related to elevated soluble ST2 concentrations and survival in patients with heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources